Article List

WPRIM Management System> DCMS> Journal of Gastric Cancer> 2010> 10> 4

Volume: 10 Issue: 4

1. Microsatellite Instability Is Associated with the Clinicopathologic Features of Gastric Cancer in Sporadic Gastric Cancer Patients.	Page:149—154
2. In Vitro Adenosine Triphosphate Based Chemotherapy Response Assay in Gastric Cancer.	Page:155—161
3. In Vitro Adenosine Triphosphate Based Chemotherapy Response Assay in Gastric Cancer.	Page:155—161
4. Frequency and Predictive Factors of Lymph Node Metastasis in Mucosal Cancer.	Page:162—167
5. Frequency and Predictive Factors of Lymph Node Metastasis in Mucosal Cancer.	Page:162—167
6. Phenotypic Differences of Gastric Cancer according to the Helicobacter pylori Infection in Korean Patients.	Page:168—174
7. Phenotypic Differences of Gastric Cancer according to the Helicobacter pylori Infection in Korean Patients.	Page:168—174
8. The Diagnostic Accuracy of Endoscopic Biopsy for Gastric Dysplasia.	Page:175—181
9. The Diagnostic Accuracy of Endoscopic Biopsy for Gastric Dysplasia.	Page:175—181
10. Is Surgical Treatment Necessary after Non-curative Endoscopic Resection for Early Gastric Cancer?.	Page:182—187
11. Is Surgical Treatment Necessary after Non-curative Endoscopic Resection for Early Gastric Cancer?.	Page:182—187
12. Image-based Approach for Surgical Resection of Gastric Submucosal Tumors.	Page:188—195
13. Image-based Approach for Surgical Resection of Gastric Submucosal Tumors.	Page:188—195
14. Prognostic Significance of Preoperative Blood Transfusion in Stomach Cancer.	Page:196—205
15. Prognostic Significance of Preoperative Blood Transfusion in Stomach Cancer.	Page:196—205
16. The Feasibility of Short Term Prophylactic Antibiotics in Gastric Cancer Surgery.	Page:206—211
17. The Feasibility of Short Term Prophylactic Antibiotics in Gastric Cancer Surgery.	Page:206—211
18. Clinicopathological Features of Upper Third Gastric Cancer during a 21-Year Period (Single Center Analysis).	Page:212—218
19. Clinicopathological Features of Upper Third Gastric Cancer during a 21-Year Period (Single Center Analysis).	Page:212—218
20. Clinicopathological Characteristics and Prognosis of Remnant Gastric Cancer.	Page:219—225
21. Clinicopathological Characteristics and Prognosis of Remnant Gastric Cancer.	Page:219—225
22. Which Is the Optimal Extent of Resection in Middle Third Gastric Cancer between Total Gastrectomy and Subtotal Gastrectomy?.	Page:226—233
23. Which Is the Optimal Extent of Resection in Middle Third Gastric Cancer between Total Gastrectomy and Subtotal Gastrectomy?.	Page:226—233
24. Feasibility of Gastric Cancer Surgery at Low Volume Hospitals.	Page:234—240
25. Feasibility of Gastric Cancer Surgery at Low Volume Hospitals.	Page:234—240
26. The Early Experience of Laparoscopy-assisted Gastrectomy for Gastric Cancer at a Low-volume Center.	Page:241—246
27. The Early Experience of Laparoscopy-assisted Gastrectomy for Gastric Cancer at a Low-volume Center.	Page:241—246
28. Comparison of Learning Curves and Clinical Outcomes between Laparoscopy-assisted Distal Gastrectomy and Open Distal Gastrectomy.	Page:247—253
29. Comparison of Learning Curves and Clinical Outcomes between Laparoscopy-assisted Distal Gastrectomy and Open Distal Gastrectomy.	Page:247—253
30. Gastric Lipomatosis.	Page:254—258
31. Gastric Lipomatosis.	Page:254—258